Literature DB >> 33016206

Integrated analysis of mRNA and microRNA expression profiles reveals differential transcriptome signature in ischaemic and dilated cardiomyopathy induced heart failure.

Xiuli Shao1, Xiaolin Zhang1, Lei Yang2, Ruijia Zhang1, Rongli Zhu1, Rui Feng1.   

Abstract

Cardiac remodelling is widely accepted as a common characteristic for many heart diseases, especially in heart failure (HF). Ischaemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) are associated with cardiac remodelling. Both mRNA and microRNA are potential diagnostic markers and therapeutic targets of cardiac remodelling in HF. However, the mechanisms of microRNA-mRNA joint regulation in HF are still unclear. In this study, 3 gene expression profiles from patients with and without HF were analysed to harvest shared differentially expressed genes (microRNA and mRNA) with significant major biological function. Moreover, key genes highly related to ICM and DCM-induced HF were screened out through a Weighted Genes Co-Expression Network Analysis (WGCNA). Based on microRNA-mRNA analysis, several microRNAs and target genes were identified. Combined with pathway analysis, we found that miR-542-3p and its target gene CILP were likely involved in the regulation of TGF-β signalling pathway in ICM induced HF. Collectively, the microRNA-mRNA interaction network analysis revealed that miR-542-3p-CILP as mediator of TGF-β signalling pathway might be a new mechanism to mediate ICM induced HF. This study provides certain novel targets for diagnosis and therapeutic treatment of ICM- and DCM-induced HF.

Entities:  

Keywords:  Heart failure; cardiac remodelling; gene expression; miRNA-mRNA network; microRNA

Mesh:

Substances:

Year:  2020        PMID: 33016206      PMCID: PMC8331008          DOI: 10.1080/15592294.2020.1827721

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  48 in total

1.  Assessment of gene expression profiles in peripheral occlusive arterial disease.

Authors:  Serban Bubenek; Anca Nastase; Ana Maria Niculescu; Sorin Baila; Vlad Herlea; Vadimir Lazar; Liliana Paslaru; Anca Botezatu; Dana Tomescu; Irinel Popescu; Simona Dima
Journal:  Can J Cardiol       Date:  2012-06-19       Impact factor: 5.223

2.  Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.

Authors:  Pratima Malekar; Marco Hagenmueller; Adamma Anyanwu; Sebastian Buss; Marcus R Streit; Celine S Weiss; David Wolf; Johannes Riffel; Alexander Bauer; Hugo A Katus; Stefan E Hardt
Journal:  Hypertension       Date:  2010-02-22       Impact factor: 10.190

3.  The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity.

Authors:  Edward F Rocnik; Peijun Liu; Kaori Sato; Kenneth Walsh; Cyrus Vaziri
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

4.  Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-β1 signaling.

Authors:  Cheng-Lin Zhang; Qian Zhao; Hui Liang; Xue Qiao; Jin-Yu Wang; Dan Wu; Li-Ling Wu; Li Li
Journal:  J Mol Cell Cardiol       Date:  2018-02-10       Impact factor: 5.000

Review 5.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

6.  Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.

Authors:  Kristin V T Engebretsen; Ida G Lunde; Mari E Strand; Anne Waehre; Ivar Sjaastad; Henriette S Marstein; Biljana Skrbic; Christen P Dahl; Erik T Askevold; Geir Christensen; Johannes L Bjørnstad; Theis Tønnessen
Journal:  FEBS J       Date:  2013-04-02       Impact factor: 5.542

7.  Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.

Authors:  Li-qing Weng; Wen-bin Zhang; Yong Ye; Pei-pei Yin; Jie Yuan; Xing-xu Wang; Le Kang; Sha-sha Jiang; Jie-yun You; Jian Wu; Hui Gong; Jun-bo Ge; Yun-zeng Zou
Journal:  Acta Pharmacol Sin       Date:  2014-07-07       Impact factor: 6.150

Review 8.  Molecular mechanisms of myocardial remodeling.

Authors:  B Swynghedauw
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

9.  MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

Authors:  Feihong Ji; Kuifeng Wang; Yu Zhang; Xin-Li Mao; Qin Huang; Jun Wang; Liping Ye; Youming Li
Journal:  J Cell Biochem       Date:  2018-10-28       Impact factor: 4.429

10.  Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions.

Authors:  Helle Wulf-Johansson; Sofie Lock Johansson; Anders Schlosser; Anne Trommelholt Holm; Lars Melholt Rasmussen; Hans Mickley; Axel C P Diederichsen; Henrik Munkholm; Tina Svenstrup Poulsen; Ida Tornøe; Vicki Nielsen; Niels Marcussen; Jørgen Vestbo; Susanne Gjørup Sækmose; Uffe Holmskov; Grith Lykke Sorensen
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

View more
  1 in total

1.  Prognostic value of cartilage intermediate layer protein 1 in chronic heart failure.

Authors:  Can Wang; Wen Jian; Qiuhu Luo; Jiasheng Cui; Yali Qing; Chunyu Qin; Gaoye Li; Wuxian Chen
Journal:  ESC Heart Fail       Date:  2021-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.